Research, Innovation & Quality

Research Team

Director – Dr Simon Whiteley

Research Sister & Coordinator – Sn Sr Elizabeth Wilby

CTA – Abigail Speight

SJUH Current Trials                      

  • UKROX -Evaluating the clinical and cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care.
  • Adapt-Sepsis- Biomarker-guided duration for sepsis
  • Remap-Cap ( Covid & Non Covid)– Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia
  • Genomiccs-Genetics of mortality in Critical Care Genetics
  • Signet– Statins for improving Organ outcome & Transplantation
  • A2B– Alpha 2 agonists for sedation to produce better outcomes from critical illness.
  • Astop- Antifungal stewardship opportunities with rapid tests for fungal infection in critically ill patients

LGI Current Trials

  • BIS-TBI The use of Bispectral Index monitoring to assess depth of sedation in patients with traumatic brain injury
  • Signet- Statins for improving Organ outcome & Transplantation
  • Genomiccs– Genetics of mortality in Critical Care Genetics
  • Tight K+- Prevention of dysthymias on the cardiac ICU- does maintenance of high normal serum levels matter?

We are also running a number of in house research and quality improvement programs including:

  • Protocolised sedation management
  • Code Red Investigations of incidents
  • Intentional Rounding
  • Safety Huddles
  • CRRT improvement program
  • Delerium identification and management
  • Sepsis recognition and timely blood cultures

There is significant opportunity to become involved in such projects whilst working with us as a trainee, trust grade doctor or advanced nurse practitioner.